Concepedia

Michael Wong

MW

Statistics

Publications

27

Citations

898

H-Index

17

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Sarepta Therapeutics (United States)

Oregon State University

Hong Kong Baptist University

United States Military Academy

Michael Wong is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1992–2017

27

Publications

27

Inhibitory Effect of the Gallotannin Corilagin on Dextran Sulfate Sodium-Induced Murine Ulcerative Colitis

Haitao Xiao, Chengyuan Lin, Derek Ho et al. · Journal of Natural Products · 2013 · 94 citations

, , +17

Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy

Dilay Hazal Ayhan, Yusuf Talha Tamer, Mohammed Akbar et al. · PLoS Biology · 2016 · 87 citations · Full text

, , +17

Safety and Pharmacokinetic Profiles of Phosphorodiamidate Morpholino Oligomers with Activity against Ebola Virus and Marburg Virus: Results of Two Single-Ascending-Dose Studies

Alison E. Heald, Patrick L. Iversen, Jay Saoud et al. · Antimicrobial Agents and Chemotherapy · 2014 · 84 citations · Full text

, , +16

Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers

James J. Howard, Carolyn R. Sturge, Dina A. Moustafa et al. · Antimicrobial Agents and Chemotherapy · 2017 · 65 citations · Full text

, , +17

AVI-7288 for Marburg Virus in Nonhuman Primates and Humans

Alison E. Heald, Jay S. Charleston, Patrick L. Iversen et al. · New England Journal of Medicine · 2015 · 62 citations · Full text

, , +17

1–5 of 27